Cynata completes strategic review of development portfolio - Dr Kilian Kelly Chief Executive Officer and Managing Director, Cynata Therapeutics Ltd 00:00:00
Dr Kilian Kelly has over 20 years’ experience in biopharmaceutical research and development. He joined the Company in March 2014 as Vice President, Product Development, and was promoted to Chief Operating Officer in May 2019, before taking on the role of CEO & MD in July 2023.